Pfizer Building Viagra As Pan-European Consumer Health Brand With Rx-To-OTC Switch In Norway

Pfizer has taken the first steps towards turning its Viagra erectile dysfunction treatment into a pan-European OTC brand by taking advantage of Norway's new "non-prescription medicines with guidance" category to secure the Rx-to-OTC switch of the product. Norway will be the second European market where Viagra is available OTC after the UK switched the drug in 2017.

Young man
• Source: Shutterstock

Pfizer Inc.’s blockbuster erectile dysfunction treatment Viagra will soon be available without a prescription in Norway after the firm secured the first Rx-to-OTC switch into the country’s newly created “non-prescription medicines with guidance” category.

More from Rx-to-OTC Switch

More from Health